Wednesday, February 22, 2017
   
Text Size

GLOBAL FUND to Fight AIDS, Tuberculosis and Malaria


Bookmark and Share

Drug Resistant Tuberculosis

Institute of Human Virology Nigeria (IHVN) was selected in 2011 as the Principal Recipient of the Global Fund to Fight AIDS, Tuberculosis and Malaria Round 9 Multi-drug Resistant Tuberculosis (MDR-TB) Grant. The goal of the grant is to strengthen MDR-TB prevention and control in Nigeria. IHVN is partnering with the National Tuberculosis and Leprosy Control Program (NTBLCP) of the Federal Ministry of Health (FMoH) and other stakeholders in the implementation of the scale up of the programmatic management of drug resistant TB (PMDT). On receiving the Grant, the NTBLCP (also a Sub-Recipient to the grant), set up a coordinating mechanism for the MDR-TB program and supported IHVN and other partners in setting up implementation structures for intervention activities. Phase 1 recorded a recent grant rating of A1, with 168 patients commenced on treatment across seven treatment centres that were activated.

In Phase 2, the activities supported by the grant include infrastructural upgrade, supply of equipment and maintenance of some treatment centres and reference laboratories; and supply of reagents, consumables and data collection tools. The Institute also carried out capacity building for treatment centres, laboratory and state TB staff on service provision and data collection; sputum transportation logistics nationwide to increase case detection; strengthened routine surveillance for MDR-TB at all levels; and established and supported State MDR-TB Teams for strengthening oversight and supervision of patient management.

With support from the Global Fund and other partners, there have been 125,179 presumptive cases for DR-TB that have been tested for DR-TB, over 1800 patients have began second-line treatment for DR-TB (July 2011 – September 2016). Also 1,523 service providers have been trained in the following areas: clinical and programmatic management of DR-TB, laboratory techniques for TB culture, DST and Line Probe Assay, DR-TB recording and reporting tools and data management, pharmaceutical practices and LMIS and Community support for DR-TB patients. The treatment centres providing DR-TB services are:

  • Abubakar Tafawa Balewa University Teaching Hospital, Bauchi State
  • Jos University Teaching Hospital, Plateau State
  • University College Hospital, Ibadan (UCH), Oyo State
  • Government Chest Hospital, Jericho, Ibadan, Oyo State
  • University of Uyo Teaching Hospital, Uyo, (UUTH), Akwa-Ibom State
  • University of Port Harcourt Teaching Hospital, Port Harcourt (UPTH). Rivers State
  • Dr. Lawrence Henshaw Memorial Hospital, Calabar, Cross River State
  • National Tuberculosis and Leprosy Training Center, Zaria (NTBLTC), Kaduna State
  • Infectious Diseases Hospital, Kano State
  • Sacred Hearts Hospital, Abeokuta., Ogun State
  • Federal Medical Center Owerri, Imo State
  • State Specialist Hospital, Sokoto, Sokoto State
  • State Hospital Jalingo, Taraba
  • St. Vincent Alaide Benue State
  • General Hospital Iwo, Osun State

The currently operational TB Reference Laboratories are:

National Institute for Medical Research (National) National Tuberculosis Leprosy Training Center (National) University College Hospital (South West) Aminu Kano Teaching Hospital (North West) Dr. Lawrence Henshaw Memorial Hospital Calabar (South South), Zankli Hospital (North Central), Jos University Teaching Hospital, and University of Port Harcourt Teaching Hospital.

In addition, IHVN partners with the following International Federation of Anti-Leprosy Associations (ILEP); (German Leprosy Relief Association (GLRA), Netherlands Leprosy Relief (NLR), Damien Foundation Belgium (DFB), The Leprosy Mission of Nigeria (TLMN) and Health Alive Foundation for state and community level activities.

Malaria

Institute of Human Virology, Nigeria (IHVN) is working with the National Malaria Elimination Program (NMEP) as a sub-recipient to implement malaria control activities in Nigeria. IHVN implemented the Global Fund Round 8 Phase 1 & 2 Grant in Akwa Ibom, Benue, Borno, Gombe, Kano, Katsina, Kebbi, Kogi, Kwara, Ogun, Plateau and Sokoto. The implementation period spanned from 2010 - 2015. The Institute was involved with the distribution and support for prevention with the use of insecticide-treated nets (LLIN), Behaviour Change Communication activities, diagnosis and treatment using Artemisinin based combination therapy and Health Systems Strengthening in 1,830 facilities across supported States.

The current Global Fund Malaria New Funding Model (NFM) grant, titled 'Contributing to rapid and sustained scale-up of malaria control interventions for impact in Nigeria' will be implemented from June 2015 to December 2016 in 24 priority States. The National Malaria Elimination Program (NMEP) is the Principal Recipient (PR) for public sector. Institute of Human Virology, Nigeria (IHVN) as a Sub-Recipient to NMEP will be collaborating with Katsina, Jigawa, Kogi and Benue States to implement the expectations of the grant, with the aim of further reducing the burden of malaria in Jigawa State. The key modules which will be implemented in the remaining period of 2015 and 2016 include:

The treatment centres providing DR-TB services are:

  • Vector Control
  • Case management of uncomplicated and severe malaria including community level intervention
  • Specific Prevention Intervention-IPTp
  • Product, Supply Chain management (PSCM)
  • Health Information Systems and Monitoring & Evaluation (HIS & M&E)
  • Program Management

At the State level, IHVN will

  • Train health care providers and other relevant staff of the State Ministry of Health and LGA Department of Health.
  • Ensure provision of drugs and commodities in selected public health facilities across the State as follows:

    1. Malaria Rapid Diagnostic Test kits and Artemisinin Combination Therapy for free diagnosis and treatment
    2. Sulphadoxine/Pyrimethamine for Intermittent Prevention of Malaria in Pregnancy
    3. Long Lasting Insecticide Treated Nets at selected public health facilities for routine distribution through antenatal and immunization clinics, and continuous distribution channels
  • Community Case Management of Malaria using Role Model Caregivers (RMCs)
  • Support for routine monitoring and evaluation, as well as supportive supervision

HIV

IHVN is a sub-recipient to the National Agency for the Control of AIDS (NACA) implementing the Global Fund HIV New Funding Model (NFM) grant and providing services in the areas of HIV Testing and Counseling (HTC), prevention of mother-to-child transmission (PMTCT), anti-retroviral treatment (ART) and sexual and reproductive health services in 46 Comprehensive and 164 primary health care centers across eight states.

:: Privacy Policy

IHVN frowns at reproduction of the content of this website without prior permission.This act is illegal and punishable under the law.

:: Support and Funding

The Institute of Human Virology, Nigeria AITRP Training Programmes are supported and funded by the Fogarty International Center.
FacebookTwitterGoogleYoutube

IHVN Member's Logon